Precision Therapeutics Inc. company info

CIK 1446159
IRS Number 331007393
State of incorporation DE
Business address 2915 COMMERS DRIVE,
Mail address 2915 COMMERS DRIVE,

Short summary

Precision Therapeutics Inc. is a Minnesota company, with head office located at 2915 Commers Drive, Eagan, Minnesota 55121. In 2018 the company owned a total of 5.09 million USD worth of assets, including 3.65 million USD worth of current assets. The company amassed the most assets last year, totalling up to 5.09 million USD.

Precision Therapeutics Inc. Income Statement

Name [in Millions USD]200120022003200420052006200720082009201020112012201320142015201620172018Trends
Cost of Goods and Services Sold
Gross Profit
Research and development 0.100.0100.020.240.390.260.410.290.53
Operating Expenses 6.057.86
Interest expense
Income Tax Expense (Benefit) 000
Net income -1.35-4.49-7.42-9.41-6.83

Precision Therapeutics Inc. Balance Sheet

Name [in Millions USD]200120022003200420052006200720082009201020112012201320142015201620172018Trends
Cash and cash equivalents 00.460.
Accounts Receivable, Net, Current
Property, Plant and Equipment, Gross
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Intangible Assets, Net (Excluding Goodwill)
Total assets
Current assets
Accounts payable 0.810.730.660.661.632.470.750.060.170.43
Total current liabilities 0.481.431.922.453.393.916.891.551.260.934.76
Long-term Debt, Excluding Current Maturities 0.130.660.0900
Total liabilities 3.674.206.892.111.330.645.02
Common Stock, Value, Issued
Retained Earnings (Accumulated Deficit) 0.01-35.64-45.23-50.90-58.90-66.40
Accumulated Other Comprehensive Income (Loss), Net of Tax 0.01

Precision Therapeutics Inc. Cash Flow

Name [in Millions USD]200120022003200420052006200720082009201020112012201320142015201620172018Trends
Net income -1.35-4.49-7.42-9.41-6.83
Amortization of Intangible Assets
Depreciation and amortization
Accounts receivable 0.02-0.020.05-0.010.06-0.04-
Inventories 00.100.05-0.020.25-0.140.04-0.01-0.02
Accounts payable 1.13-1.54-0.43-0.080.31
Deferred revenue 00.07-0.060.00-0.00
Net Cash Provided by (Used in) Operating Activities -1.31-0.82-1.78-1.18-4.38-4.46-5.29
Payments to Acquire Property, Plant, and Equipment 00000.
Payments to Acquire Intangible Assets 00000.
Net Cash Provided by (Used in) Investing Activities 0000-0.42-1.65-1.11
Net Cash Provided by (Used in) Investing Activities, Continuing Operations 0-0.22-0.12-0.06-0.42
Proceeds from Issuance of Long-term Debt 0.100.600.530.531.821.50
Proceeds from Issuance of Common Stock 0.630.221.390.702.340.1613.051.713.812.96
Payments for Repurchase of Common Stock -0.170
Net Cash Provided by (Used in) Financing Activities 0.860.811.901.071.715.115.79
Cash and Cash Equivalents, Period Increase (Decrease) -0.45-0.010.11-0.110.09-0.09-3.09-1.00